Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30970216 | 0.92 | AGTR2 (0.51) | AGTR2CYP3A4 | |
| SCHEMBL30970213 | 0.87 | AGTR2 (0.53) | AGTR2CYP3A4 | |
| SCHEMBL30970217 | 0.87 | AGTR2 (0.53) | AGTR2CYP3A4 | |
| SCHEMBL30970220 | 0.85 | AGTR2 (0.56) | AGTR2CYP3A4 | |
| SCHEMBL30970211 | 0.85 | AGTR2 (0.53) | AGTR2CYP3A4 | |
| SCHEMBL30970214 | 0.85 | AGTR2 (0.51) | AGTR2CYP3A4 | |
| SCHEMBL30970203 | 0.84 | KDM4E (0.46) | AGTR2 | |
| SCHEMBL30970239 | 0.83 | AGTR2 (0.54) | AGTR2CYP3A4 | |
| SCHEMBL30195019 | 0.82 | AGTR2 (0.55) | AGTR2CYP3A4 | |
| SCHEMBL30970243 | 0.81 | AGTR2 (0.58) | AGTR2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4648850-A1 | SELECTIVE ANGIOTENSIN II COMPOUNDS | Vicore Pharma AB (SE) | 2025-11-19 | — | — | EP | claimed |
| WO-2024149712-A1 | SELECTIVE ANGIOTENSIN II COMPOUNDS | VICORE PHARMA AB (SE) | 2024-07-18 | — | — | WO | claimed |
| EP-4648850-A1 | SELECTIVE ANGIOTENSIN II COMPOUNDS | Vicore Pharma AB (SE) | 2025-11-19 | — | — | EP | disclosed |
| WO-2024149712-A1 | SELECTIVE ANGIOTENSIN II COMPOUNDS | VICORE PHARMA AB (SE) | 2024-07-18 | — | — | WO | disclosed |